Citation Impact
Citing Papers
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Intestinal hormones and plasma insulin: an insulinotropic action of secretin.
1967
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum
2003
Distal Small Bowel Hormones (Correlation with Fasting Antroduodenal Motility and Gastric Emptying)
1998
Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans
1999
Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005
2006
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines
2007 StandoutNatureNobel
Prohormone Convertase 1/3 Is Essential for Processing of the Glucose-dependent Insulinotropic Polypeptide Precursor
2006
Osteoblast-Derived Cells Express Functional Glucose-Dependent Insulinotropic Peptide Receptors1
2000
Gastric Inhibitory Polypeptide–Dependent Cortisol Hypersecretion — A New Cause of Cushing's Syndrome
1992
An Extract ofGymnema sylvestre Leaves and Purified Gymnemic Acid Inhibits Glucose-Stimulated Gastric Inhibitory Peptide Secretion in Rats
1992
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety—effect of obesity and weight reduction
2001
Drug penetration in solid tumours
2006 Standout
What do we know about the secretion and degradation of incretin hormones?
2005
Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity
1995
Cell signalling of the GLP-1 action in rat liver
2003
Glucose-Dependent Insulinotropic Polypeptide Confers Early Phase Insulin Release to Oral Glucose in Rats: Demonstration by a Receptor Antagonist1
2000
Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
1999
Influence of melatonin and serotonin on glucose‐stimulated insulin release from perifused rat pancreatic islets in vitro
1997
Cardiovascular risk continuum: implications of insulin resistance and diabetes
1998
Classification and functions of enteroendocrine cells of the lower gastrointestinal tract
2011
Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant
2000 StandoutNatureNobel
The Glucagon‐Like Peptides
2006
Electrical activity‐triggered glucagon‐like peptide‐1 secretion from primary murine L‐cells
2011
Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor
1996
Endogenous mutagens and the causes of aging and cancer
1991
Glucagon-like peptide-1 inhibits glucagon-induced glycogenolysis in perivenous hepatocytes specifically
2003
Biology of Incretins: GLP-1 and GIP
2007 Standout
Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients
2001
Incretin Secretion in Relation to Meal Size and Body Weight in Healthy Subjects and People with Type 1 and Type 2 Diabetes Mellitus
2003
Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequences
1995
Glucagon-like peptide 1(GLP-1) in biology and pathology
2005
Melatonin's Role in Vertebrate Orcadian Rhythms
1998
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects
2001
Functional receptors for the insulinotropic hormone glucagon‐like peptide‐I(7–37) on a somatostatin secreting cell line
1991
The Effects of Treatment with Recombinant Human Growth Hormone on Body Composition and Metabolism in Adults with Growth Hormone Deficiency
1989 Standout
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
2005
Effects of short-term chemical ablation of the GIP receptor on insulin secretion, islet morphology and glucose homeostasis in mice
2004
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Neural regulation of glucagon-like peptide-1 secretion in pigs
2004
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
2003
Is visceral obesity the cause of the metabolic syndrome?
2006
INTESTINAL HORMONES AND PLASMA-INSULIN
1967
Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes
2002
FMRFamide reverses protein phosphorylation produced by 5-HT and cAMP in Aplysia sensory neurons
1989 StandoutNatureNobel
Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice
2002
The Physiology of Glucagon-like Peptide 1
2007 Standout
Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin
2003
Effect of GLP-1 on glucose transport and its cell signalling in human myocytes
2004
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Vesicle fusion following receptor-mediated endocytosis requires a protein active in Golgi transport
1989 StandoutNatureNobel
The Drosophila takeout Gene Is a Novel Molecular Link between Circadian Rhythms and Feeding Behavior
2000 StandoutNobel
Glucagon-Like Peptide-1, Peptide YY, Hunger, and Satiety after Gastric Bypass Surgery in Morbidly Obese Subjects
2006
The vagus is inhibitory of the late postprandial insulin secretion in conscious pigs
2002
Placebo interventions for all clinical conditions
2004
Leptin and the regulation of body weight in mammals
1998 StandoutNature
Fasting Insulin and Apolipoprotein B Levels and Low-Density Lipoprotein Particle Size as Risk Factors for Ischemic Heart Disease
1998
Protein Kinase Cζ Is Required for Oleic Acid-Induced Secretion of Glucagon-Like Peptide-1 by Intestinal Endocrine L Cells
2006
Glucagon-Like Peptide-1 7-36 Amide and Peptide YY Have Additive Inhibitory Effect on Gastric Acid Secretion in Man
1997
The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-l, but not to glucose-dependent insulinotropic polypeptide, in the portal vein
1996
Cell and Molecular Biology of the Incretin Hormones Glucagon-Like Peptide-I and Glucose-Dependent Insulin Releasing Polypeptide
1995
The major glucagon-like peptide-1 metabolite, GLP-1-(9–36)-amide, does not affect glucose or insulin levels in mice
2004
Zero-length crosslinking procedure with the use of active esters
1990
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Muscarinic Receptors Control Glucagon-Like Peptide 1 Secretion by Human Endocrine L Cells
2003
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
1998
Glucagon-Like Peptide 1 Induces Natriuresis in Healthy Subjects and in Insulin-Resistant Obese Men
2004
Radioimmunoassay in Gastroenterology
1972 StandoutNobel
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Glucagon Receptors in β-Cells
1972
Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum
2000
Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose
1968
Free fatty acid estimation by a semi-automated fluorimetric method
1973
STIMULATION BY GLUCAGON OF INSULIN RELEASE FROM RABBIT PANCREAS IN VITRO
1966
Effect of Prostaglandins on Gatecholamine Induced Changes in the Free Fatty Acids of Plasma and in Blood Pressure in the Dog Prostaglandin and related factors 22
1964 StandoutNobel
Role of Leptin in the Regulation of Glucagon-Like Peptide-1 Secretion
2003
Presence of glucagon and glucagon-like peptide-1-(7-36)amide receptors in solubilized membranes of human adipose tissue.
1993
EXTRA-GASTROINTESTINAL EFFECTS OF SECRETIN, GASTRIN, AND PANCREOZYMIN
1968
Neurexin III alpha: extensive alternative splicing generates membrane-bound and soluble forms.
1993 StandoutNobel
Synthetic Polypeptide Antagonists of the Hypothalamic Luteinizing Hormone Releasing Factor
1972 StandoutScienceNobel
Immunological and chemical characterization of bovine preproinsulin.
1977
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE
1974 StandoutNobel
1 Immunopharmacology of Gold
1982
Goitrogenic and estrogenic activity of soy isoflavones.
2002
Rapid Oscillations in Plasma Glucagon-Like Peptide-1 (GLP-1) in Humans: Cholinergic Control of GLP-1 Secretion via Muscarinic Receptors1
1997
Studies of pancreatic alpha cell function in normal and diabetic subjects
1970
Fusion between endocytic vesicles in a cell-free system.
1987
Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man
1969
INTESTINAL HORMONES AND PLASMA-INSULIN
1966
The Steroid and Thyroid Hormone Receptor Superfamily
1988 StandoutScience
Toward Development of Assays for Scrapie-Specific Antibodies
1981 StandoutNobel
Prostaglandins: Members of a New Hormonal System
1967 StandoutScienceNobel
The Reaction of Glucagon with Its Receptor: Evidence for Discrete Regions of Activity and Binding in the Glucagon Molecule
1971 StandoutNobel
A Meta-Analysis of the Effect of Glucagon-Like Peptide-1 (7–36) Amide on Ad Libitum Energy Intake in Humans
2001
Basal Plasma Glucagon Levels of Man*
1967
Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue.
1993
Role of the Vagus Nerve in Mediating Proximal Nutrient-Induced Glucagon-Like Peptide-1 Secretion*
1999
Somatostatin Inhibition of Insulin and Gastrin Hypersecretion in Pancreatic Islet-Cell Carcinoma
1975 StandoutNobel
Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow
1998
Dipeptidyl Peptidase IV Inhibition Reduces the Degradation and Clearance of GIP and Potentiates Its Insulinotropic and Antihyperglycemic Effects in Anesthetized Pigs
2001
Morphinomimetic activity of synthetic fragments of beta-lipotropin and analogs.
1976 StandoutNobel
Identification and Actions of Gastric Inhibitory Polypeptide
1975
Insulin release induced by glucagon in organ cultures of fetal rat pancreas
1966
Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1
1996
Endorphins: Profound Behavioral Effects in Rats Suggest New Etiological Factors in Mental Illness
1976 StandoutScienceNobel
Glucose-Sensing in Glucagon-Like Peptide-1-Secreting Cells
2002
GLUCAGON CONTROL OF FASTING GLUCOSE IN MAN
1974 StandoutNobel
Glucose and lipid homeostasis in the absence of human growth hormone
1971
Effects of Glucagon on Lipolysis and Ketogenesis in Normal and Diabetic Men
1974
Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells.
1992
Activation of guanyl cyclase and adenyl cyclase by secretin
1973
Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.
1987
Plasma insulin in health and disease
1961 StandoutNobel
GLP-1 does not acutely affect insulin sensitivity in healthy man
1996
Inhibition of dibutyryl cyclic amp-induced insulin release by alpha-2 adrenergic stimulation
1983
Creutzfeldt–Jakob Disease Prion Proteins in Human Brains
1985 StandoutNobel
Distribution of immunoassayable glucagon in gastrointestinal tissues
1966
Regional dissociation of beta-endorphin and enkephalin contents in rat brain and pituitary.
1977 StandoutNobel
Foot-shock induced stress increases β-endorphin levels in blood but not brain
1977 StandoutNatureNobel
The gastrointestinal stimulus to insulin release
1969
Incretin Effects of Increasing Glucose Loads in Man Calculated from Venous Insulin and C-Peptide Responses*
1986
Chemical Ablation of Gastric Inhibitory Polypeptide Receptor Action by Daily (Pro3)GIP Administration Improves Glucose Tolerance and Ameliorates Insulin Resistance and Abnormalities of Islet Structure in Obesity-Related Diabetes
2005
Characterization of an antiserum against the glucocorticoid receptor
1981
Placebo interventions for all clinical conditions
2010
Stimulation of Adenosine 3′:5′-Cyclic Monophosphate Accumulation in Anterior Pituitary Gland In Vitro by Synthetic Luteinizing Hormone-Releasing Hormone
1972 StandoutNobel
Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential
1999
Structural evidence for glucagon producing cells in the intestinal mucosa of the rat
1968
Effect of Prostaglandin E1on Plasma Free Fatty Acids and Blood Glucose in the Dog Prostaglandin and related factors 51
1966 StandoutNobel
Leucine-induced hypoglycemia
1960
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
1967
The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation.
1997
Immunoassay of protein and peptide hormones
1964 StandoutNobel
Merosin, a tissue-specific basement membrane protein, is a laminin-like protein.
1990
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Crystal structure of leucine-enkephalin
1983 StandoutNatureNobel
Hypertriglyceridemic Waist
2000
Radioimmunoassayable glucagon levels in man: effects of starvation, hypoglycemia, and glucose administration.
1966
A Novel Glucose-Sensing Mechanism Contributing to Glucagon-Like Peptide-1 Secretion From the GLUTag Cell Line
2003
Role of Gastrointestinal Hormones in Postprandial Reduction of Bone Resorption
2003
Biosynthetic origin and receptor conformation of methionine enkephalin
1976 Nature
The gold complexes
1990
Cloning and characterization of a functional human homolog of Escherichia coli endonuclease III
1997 StandoutNobel
Endocytic and exocytic pathways of the neuronal secretory process and trans synaptic transfer of wheat germ agglutinin‐horseradish peroxidase in vivo
1985
β-Endorphin and Adrenocorticotropin Are Selected Concomitantly by the Pituitary Gland
1977 StandoutScienceNobel
A Human Cellular Model for Studying the Regulation of Glucagon-Like Peptide-1 Secretion
2001
Isolation, primary structure, and synthesis of α-endorphin and γ-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity
1976 StandoutNobel
Types of endocrine cells in the human colon and rectum
1978
C fragment of lipotropin has a high affinity for brain opiate receptors
1976 Nature
Studies on the Role of Adenosine 3',5'-Monophosphate in the Hepatic Actions of Glucagon and Catecholamines
1971 StandoutNobel
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients
2011 Standout
A cellular gene encodes scrapie PrP 27-30 protein
1985 StandoutNobel
The structure and evolution of the two nonallelic rat preproinsulin genes
1979 StandoutNobel
Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3',5'-monophosphate formation.
1977 StandoutNobel
The Glucagon-Like Peptides
1999
Influence of Intrajejunal Glucose on Pancreatic Exocrine Function in Man
1971
An Analog of Enkephalin Having Prolonged Opiate-Like Effects in Vivo
1977 StandoutScienceNobel
EFFECT OF GLUCAGON ON INSULIN RELEASE IN VITRO
1966
Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels
1978
FAILURE OF ENDOGENOUS STIMULATION OF SECRETIN AND PANCREOZYMIN RELEASE TO INFLUENCE SERUM-INSULIN
1968
A clinician's primer on the circadian clock: its localization, function, and resetting.
1993
Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: In Vivo and in Vitro Studies in Rats
2002
The Effects of Secretin, Pancreozymin, and Gastrin on Insulin and Glucagon Secretion in Anesthetized Dogs *
1967
A New Chromogenic β‐Galactosidase Substrate: 7‐β‐D ‐Galactopyranosyloxy‐9,9‐dimethyl‐9H‐acridin‐2‐one
1991
Progress report. Radioimmunoassay of intestinal hormones.
1974
Glucagon-Like Peptide-1, But Not Glucose-Dependent Insulinotropic Peptide, Regulates Fasting Glycemia and Nonenteral Glucose Clearance in Mice*
2000
Initiation of Increased Pancreatic Islet Growth in Young Normoglycemic Mice (Umea +/?)*
1999
Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor.
1996
IDENTIFICATION OF CELLS WITH PANCREATIC‐TYPE AND GUT‐TYPE GLUCAGON IMMUNOREACTIVITY IN THE HUMAN COLON
1975
Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice
1999
Comparison of the Kinetics of Parenteral and Oral Gold
1983
Neuronal actions of endorphins and enkephalins among brain regions: a comparative microiontophoretic study.
1977 StandoutNobel
Pancreatic Islet Cell Carcinoma
1973
EFFECTS OF SECRETIN ON INSULIN AND GLUCAGON IN PORTAL AND PERIPHERAL BLOOD IN MAN
1966
Preproinsulin, a new precursor in insulin biosynthesis
1977
Antibodies to a scrapie prion protein
1984 StandoutNatureNobel
Gold in erythrocytes, whole blood, and plasma during long-term chrysotherapy.
1980
Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats.
1996
Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day
1996
A genetic approach to trace neural circuits
1999 StandoutNobel
Effects of Somatostatin on Plasma Glucose and Glucagon Levels in Human Diabetes Mellitus
1974 StandoutNobel
Radioimmunological determination of pancreatic and gut glucagon in plasma
1971
5′-Guanylylimidodiphosphate, A Potent Activator of Adenylate Cyclase Systems in Eukaryotic Cells
1974 StandoutNobel
Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: In Vivo and in Vitro Studies in Rats
2002
Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential
2005
Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids
1968
Works of V. Marks being referenced
Streptozotocin treatment of malignant islet cell tumour.
1970
Polypeptide Hormones: Molecular and Cellular Aspects.
1977
Attenuated GLP-1 secretion in obesity: cause or consequence?
1996
Glucagon-like peptide-1(7–36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns
1993
The order of islet microvascular cellular perfusion is B----A----D in the perfused rat pancreas.
1988
Modifications of gastric inhibitory polypeptide (GIP) secretion in man by a high-fat diet
1988
GIP and GLP-1(7–36)amide secretion in response to intraduodenal infusions of nutrients in pigs
1995
Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7–36) amide, on fatty acid synthesis in explants of rat adipose tissue
1991
Dietary maladvice as a cause of hypothyroidism and short stature.
1989
Plasma and Intestinal Concentrations of GIP and GLP-1(7-36)Amide During Suckling and After Weaning in Pigs
1995
Immunocytochemical localisation of VP16-213 in normal and malignant tissues
1987
The effect of dietary modification and hyperglycaemia on gastric emptying and gastric inhibitory polypeptide (GIP) secretion
1988
EVIDENCE FOR PREFERENTIAL STIMULATION OF GASTRIC INHIBITORY POLYPEPTIDE SECRETION IN THE RAT BY ACTIVELY TRANSPORTED CARBOHYDRATES AND THEIR ANALOGUES
1980
Insulin Assay in Insulinomas
1963
Tissue gold levels after chrysotherapy.
1974
Insulin and C-Peptide Levels After Oral and Intravenous Glucose: Contribution of Enteroinsular Axis to Insulin Secretion
1986
Effects of fatty acid chain length and saturation on gastric inhibitory polypeptide release in obese hyperglycaemic (ob/ob) mice
1985
Some effects of jet-lag and their alleviation by melatonin
1987
Intestinal Factors in the Regulation of Insulin Secretion
1970
An improved glucose-oxidase method for determining blood C.S.F. and urine glucose levels
1959
Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice
1984
Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study.
1994
Plasma Growth-hormone Levels in Chronic Starvation in Man
1965 Nature
24‐HOUR PROFILES OF MELATONIN, CORTISOL, INSULIN, C‐PEPTIDE AND GIP FOLLOWING A MEAL AND SUBSEQUENT FASTING
1982
Physiologic Observations in a Controlled Clinical Trial of the Antiemetic Effectiveness of 5, 10, and 15 mg of Δ9‐Tetrahydrocannabinol in Cancer Chemotherapy. Ophthalmologic Implications
1981
Tissue dispostion and excretion of gold and14C in rats treated with sodium aurothio[1,4-14C]malate or thio [1,4-14C] malic acid
1985
The Entero-Insular Axis in Polycystic Ovarian Syndrome
1996
Enzyme Immunoassay: A Review
1979
Radioimmunoassay of Gastric Inhibitory Polypeptide
1978
Measurement of Potato Steroidal Alkaloids in Human Serum and Saliva by Radioimmunoassay
1985
BLOOD AND URINE GOLD LEVELS DURING CHRYSOTHERAPY FOR RHEUMATOID ARTHRITIS
1975
IMMUNOCHEMICAL GLUCAGON IN HUMAN PANCREAS, GUT, AND PLASMA
1966
Comparison of two methods of preparing enzyme-antibody conjugates: Application of these conjugates for enzyme immunoassay
1979
A simple method for the preparation of enzyme—antibody conjugates
1978
Immunoreactive C-Peptide in Spontaneous Syndromes of Obesity and Diabetes in Mice
1987
Effect of pretreatment with a high fat diet on the gastric inhibitory polypeptide and insulin responses to oral triolein and glucose in rats
1983
ENHANCEMENT OF GLUCOSE-STIMULATED INSULIN RELEASE BY AN INTESTINAL POLYPEPTIDE IN RATS
1972
Gastrointestinal apudosis in obese hyperglycaemic mice
1975
The Measurement of Insulin-Like Growth Factor I: Clinical Applications and Significance
1986
PROMOTION OF INSULIN SECRETION BY GLUCAGON
1965
Interrelationship of Glucagon, Insulin and Glucose: The Insulinogenic Effect of Glucagon
1966
Elevated Post-Prandial Gastric Inhibitory Polypeptide Concentrations in Hypertriglyceridaemic Subjects
1997
Inhibition of carbohydrate-mediated glucagon-like peptide-I (7–36)amide secretion by circulating non-esterified fatty acids
1999
Evaluation of a colorimetric method (Duncombe) of determination of plasma non-esterified fatty acids
1966
Abnormalities of GIP in Spontaneous Syndromes of Obesity and Diabetes in Mice
1983
STIMULATION OF GLUCAGON SECRETION BY ORAL GLUCOSE
1965
Inhibition of carbohydrate-mediated glucagon-like peptide-1 (7‒36)amide secretion by circulating non-esterified fatty acids
1999
A LEUCINE-SENSITIVE INSULIN-SECRETING TUMOUR
1960
Immunoreactive gastric inhibitory polypeptide and K cell hyperplasia in obese hyperglycaemic (ob/ob) mice fed high fat and high carbohydrate cafeteria diets
1986